Learn more about EnGeneIC Dream Vector (EDV™) Nanocell platform technology
Publication in prestigious scientific journal, Cancer Cell, highlighting the ability of EDV™ Nanocells to mount dual assault on Cancer Cells
EDV™ Technology Stimulates Both Innate and Adaptive Immune Response and Confers Long-Term Survival
Abstract accepted to the Annual Meeting of the American Society of Clinical Oncology 2020
Abstract Demonstrates Promising Early Results from Phase I/IIa study in Patients with Recurrent, Metastatic Pancreatic Cancer.